ACTIV-3b: Therapeutics for Severely Ill Inpatients With COVID-19

NCT04843761 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

473

Enrollment

NIH

Sponsor class

Conditions

Covid19

Interventions

BIOLOGICAL: Remdesivir
DRUG: Remdesivir Placebo
BIOLOGICAL: Aviptadil
DRUG: Aviptadil Placebo
DRUG: Corticosteroid

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]